메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 26, Issue 15, 2008, Pages 2593-2596
In reply
Author keywords

[No Author keywords available]
Indexed keywords

ANTINEOPLASTIC AGENT; PROTON;
EID: 51349146512     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.16.5662     Document Type: Letter
Times cited : (4)
References (12)
  • 1
    • 45149123366 scopus 로고    scopus 로고
    • Protons and parachutes
    • Tepper J: Protons and parachutes. J Clin Oncol 26:2436-2437, 2008
    • (2008) J Clin Oncol , vol.26 , pp. 2436-2437
    • Tepper, J.1
  • 2
    • 45149103248 scopus 로고    scopus 로고
    • Should randomized trials be required for proton radiotherapy? An alternative view
    • Glatstein E, Glick J, Kaiser L, et al: Should randomized trials be required for proton radiotherapy? An alternative view. J Clin Oncol 26:2438-2439, 2008
    • (2008) J Clin Oncol , vol.26 , pp. 2438-2439
    • Glatstein, E.1    Glick, J.2    Kaiser, L.3
  • 3
    • 45149121699 scopus 로고    scopus 로고
    • Proton therapy should be tested in randomized trials
    • Macbeth F, Williams M: Proton therapy should be tested in randomized trials. J Clin Oncol 26:2590-2591, 2008
    • (2008) J Clin Oncol , vol.26 , pp. 2590-2591
    • Macbeth, F.1    Williams, M.2
  • 4
    • 45149118853 scopus 로고    scopus 로고
    • On equipoise and emerging technologies
    • Lewis B: On equipoise and emerging technologies. J Clin Oncol 26:2590, 2008
    • (2008) J Clin Oncol , vol.26 , pp. 2590
    • Lewis, B.1
  • 6
    • 0025906439 scopus 로고
    • Of mice but not men: Problems of the randomized clinical trial
    • Hellman S, Hellman DS: Of mice but not men: Problems of the randomized clinical trial. N Engl J Med 324:1585-1589, 1991
    • (1991) N Engl J Med , vol.324 , pp. 1585-1589
    • Hellman, S.1    Hellman, D.S.2
  • 7
    • 0021134641 scopus 로고
    • Compensating for heterogeneities in proton radiation therapy
    • Urie M, Goitein M, Wagner M: Compensating for heterogeneities in proton radiation therapy. Phys Med Biol 29:553-566, 1984
    • (1984) Phys Med Biol , vol.29 , pp. 553-566
    • Urie, M.1    Goitein, M.2    Wagner, M.3
  • 8
    • 39149105939 scopus 로고    scopus 로고
    • Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted?
    • Suit H, Kooy H, Trofimov A, et al: Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No. Radiother Oncol 86:148-153, 2008
    • (2008) Radiother Oncol , vol.86 , pp. 148-153
    • Suit, H.1    Kooy, H.2    Trofimov, A.3
  • 9
    • 0034333021 scopus 로고    scopus 로고
    • Overpriced technology in radiation oncology
    • Halperin EC: Overpriced technology in radiation oncology. Int J Radiat Oncol Biol Phys 48:917-918, 2000
    • (2000) Int J Radiat Oncol Biol Phys , vol.48 , pp. 917-918
    • Halperin, E.C.1
  • 10
    • 28844435764 scopus 로고    scopus 로고
    • Number of patients potentially eligible for proton therapy
    • Glimelius B, Anders A, Bjelkengren G, et al: Number of patients potentially eligible for proton therapy. Acta Oncol 44:836-849, 2005
    • (2005) Acta Oncol , vol.44 , pp. 836-849
    • Glimelius, B.1    Anders, A.2    Bjelkengren, G.3
  • 11
    • 0029051605 scopus 로고
    • The patient and the public good
    • Hellman S: The patient and the public good. Nat Med 1:400-402, 1995
    • (1995) Nat Med , vol.1 , pp. 400-402
    • Hellman, S.1
  • 12
    • 45149130630 scopus 로고    scopus 로고
    • A patient's perspective on randomized clinical trials for proton radiotherapy
    • Morgan JP: A patient's perspective on randomized clinical trials for proton radiotherapy. J Clin Oncol 26:2592, 2008
    • (2008) J Clin Oncol , vol.26 , pp. 2592
    • Morgan, J.P.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.